American Cancer Society Revises Prostate Cancer Screening Guidelines
The American Cancer Society has updated its prostate cancer screening guidelines, now recommending that men aged 50-69 at average risk undergo a PSA blood test every two years. High-risk individuals, including Black men and those with a family history, should…
Tucson, AZ, November 13, 2026 — The American Cancer Society (ACS) has announced updated guidelines for prostate cancer screening, which now recommend specific testing frequencies based on an individual’s risk profile. The new recommendations aim to facilitate earlier detection of prostate cancer while also addressing concerns about potential overtreatment of the disease.
For men aged 50 to 69 who are at average risk for prostate cancer, the ACS now suggests undergoing a prostate-specific antigen (PSA) blood test every two years. This routine screening is intended to monitor for early signs of the disease in a broad segment of the male population.
The guidelines place a particular emphasis on individuals identified as being at higher risk. These include Black men, who are known to have a higher incidence of prostate cancer, and those with a documented family history of the disease. For these high-risk groups, the recommendation is to initiate screening earlier, starting at age 45. Furthermore, these individuals should undergo annual PSA testing to ensure more frequent monitoring.
The ACS stated that these updated guidelines are designed to balance the benefits of detecting prostate cancer at an early, more treatable stage against the potential harms associated with screening and subsequent treatment, such as false positives, biopsies, and treatments that may not be medically necessary for some slow-growing cancers. The organization continues to advocate for shared decision-making between patients and healthcare providers regarding screening choices.
Story summarized from the original created by AP via Scripps News Group on www.kgun9.com, see more information here.
